Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

Go back to Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
(NYSE: NSRX) Delayed: 3.80 -0.04 (1.04%)
Previous Close $3.84    52 Week High $ 
Open $3.86    52 Week Low $ 
Day High $3.91    P/E N/A 
Day Low $3.76    EPS $ 
Volume 8,328